A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

NCT05731128 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis Ulcerative

Interventions

DRUG: Dupilumab
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]